ArticleJournal of substance abuse treatment2021

Low-barrier buprenorphine during the COVID-19 pandemic: A rapid transition to on-demand telemedicine with wide-ranging effects.

Bradley M Buchheit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.